{"id":"W2158134441","doi":"10.1200/jco.2006.07.9525","title":"Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3859,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Gemcitabine; Erlotinib; Medicine; Internal medicine; Pancreatic cancer; Erlotinib Hydrochloride; Oncology; Hazard ratio; Adverse effect; Placebo; Clinical endpoint; Clinical trial; Cancer; Epidermal growth factor receptor; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002142933,0.001383767,0.002514711,0.0003634211,0.0004914634,0.001025081,0.0007437323,0.001168112,0.003962142],"category_scores_gemma":[0.001650099,0.0003822498,0.001830694,0.0006228651,0.0008236529,0.0005502077,0.0002907834,0.002722772,0.0004280246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002074574,"about_ca_system_score_gemma":0.003125771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01235901,"about_ca_topic_score_gemma":0.03469945,"domain_scores_codex":[0.9993296,0.0004143563,0.00003309946,0.00007912843,0.00006105463,0.00008271658],"domain_scores_gemma":[0.9992016,0.0001756368,0.0002415586,0.00004334639,0.00007440384,0.0002633851],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.963687,0.003850208,0.0007559969,0.0008219967,0.001223996,0.0000275436,0.00004489414,0.0005148456,0.001115337,0.00009094241,0.001902594,0.02596453],"study_design_scores_gemma":[0.9451656,0.04748755,0.004217052,0.00008084467,0.0009051238,0.00004291937,0.00002458792,0.0005818898,0.0002506364,0.00009438945,0.001131741,0.00001765442],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667326,0.01973854,0.0004343408,0.002313145,0.0006893711,0.004119412,0.001813912,0.0001026756,0.004056045],"genre_scores_gemma":[0.9770571,0.01073498,0.001431223,0.001668544,0.000502573,0.002839301,0.001476339,0.00002058365,0.004269349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01235901,"threshold_uncertainty_score":0.02457416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1918460886647593,"score_gpt":0.5307549424111981,"score_spread":0.3389088537464388,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}